vindesine has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akinaga, S; Fujiwara, H; Imada, K; Ishida, T; Ishitsuka, K; Jo, T; Miyamoto, T; Moriuchi, Y; Nosaka, K; Saburi, Y; Suzushima, H; Taira, N; Takemoto, S; Tobinai, K; Tomonaga, M; Ueda, R; Uike, N; Uozumi, K; Utsunomiya, A; Yamamoto, K; Yoshida, S | 1 |
| Chen, P; Dai, CH; Li, J; Li, XQ; Shi, SB; Wu, JR; Yu, LC | 1 |
| Batchelor, TT; Egerer, G; Engert, A; Herrlinger, U; Kowoll, A; Lamprecht, M; Linnebank, M; Patrij, K; Pels, H; Reiser, M; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Vogt-Schaden, M; Wätzel, L | 1 |
| Borsellino, N; Caruso, M; Colucci, G; Durini, E; Galetta, D; Gebbia, N; Gebbia, V; Gridelli, C; Pezzella, G; Riccardi, F; Valdesi, M; Valenza, R | 1 |
| Bosquée, L; D'Odemont, JP; Dams, N; Delobbe, A; Deman, R; Deschepper, K; Dooms, C; Galdermans, D; Nackaerts, K; Siemons, L; Van den Brande, P; Van Kerckhoven, W; Vandebroek, J; Vandeurzen, K; Vansteenkiste, J | 1 |
| Clerici, M; Cognetti, F; Crinò, L; Fossati, R; Giaccone, G; Martelli, M; Scagliotti, GV; Silvano, G; Tonato, M; Torri, V | 1 |
| Eigentler, TK; Garbe, C | 1 |
| Coiffier, B; Reyes, F | 1 |
| Azzoni, P; Cetto, GL; Genestreti, G; Manno, P; Micciolo, R; Molino, A; Pattaro, C; Santo, A; Sava, T; Terzi, A | 1 |
| Aldape, KD; Jochec, JL; Levin, VA; Shantz, LM | 1 |
| Audouin, J; Bernadou, A; Chauvenet, L; Ciaudo, M; Favier, R; Horellou, MH; Rossert, J; Samama, M | 1 |
| Bauer, J; De Grandi, P; Delaloye, JF; Leyvraz, S; Outcha Adjahoto, E | 1 |
| Brancaccio, L; Carnicelli, P; Cioffi, R; Comella, P; De Cataldis, G; Ianniello, GP; Lombardi, A; Maiorino, A; Scarpati, MD; Tinessa, V | 1 |
| Abella, E; Al-Katib, A; Heilbrun, LK; Karanes, C; Kasten-Sportes, C; Lum, L; Momin, F; Ratanatharathorn, V; Uberti, JP; Varterasian, M | 1 |
| Kobori, O; Muto, T; Nagawa, H; Seto, Y | 1 |
| Inoue, Y; Ishii, H; Ito, M; Ito, T; Kimino, K; Kishikawa, M; Kohno, S; Nakashima, M; Oka, M | 1 |
| Dams, NL; Devogelaere, RC; Humblet, YP; Marien, SA; Nackaerts, KL; Valcke, YJ; Vandebroek, JE; Vansteenkiste, JF; Verresen, DA; Weynants, P | 1 |
4 review(s) available for vindesine and Disease Exacerbation
| Article | Year |
|---|---|
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine | 2003 |
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine | 2005 |
A solitary bronchial papilloma with malignant changes.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Contraindications; Disease Progression; Electrosurgery; Humans; Keratins; Male; Mitomycin; Neoplasm Proteins; Papilloma; Parkinson Disease, Secondary; Pneumonectomy; Pulmonary Atelectasis; Serpins; Tomography, X-Ray Computed; Vindesine | 2001 |
7 trial(s) available for vindesine and Disease Exacerbation
| Article | Year |
|---|---|
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vincristine; Vindesine | 2015 |
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine | 2003 |
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Patient Compliance; Patient Selection; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2003 |
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Time Factors; Treatment Outcome; Vindesine | 2006 |
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Epirubicin; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Vindesine | 1996 |
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
7 other study(ies) available for vindesine and Disease Exacerbation
| Article | Year |
|---|---|
Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiotherapy; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2009 |
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Vindesine | 2011 |
Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO-PCV chemotherapy.
Topics: Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Disease Progression; Eflornithine; Glioma; Humans; Ornithine Decarboxylase; Survival Rate; Vindesine | 2007 |
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Peripheral; Methotrexate; Mitoguazone; Prednisone; Teniposide; Verapamil; Vincristine; Vindesine | 1995 |
Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Cisplatin; Disease Progression; Female; Humans; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms; Vindesine | 1996 |
Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vindesine; Whole-Body Irradiation | 1995 |
An experience of treatment for patients with thoracic esophageal cancer invading adjacent organs.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Humans; Lymph Node Excision; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Pulmonary Veins; Radiotherapy Dosage; Remission Induction; Survival Rate; Thorax; Trachea; Vena Cava, Superior; Vindesine | 1997 |